Johns Hopkins Singapore's Gilberto de Lima Lopes On Singapore’s Growing Importance For Phase I Trials: An Interview With PharmAsia News
This article was originally published in PharmAsia News
Government investment in translational medicine and less-rigid regulations on foreign-approved drugs is starting to show returns for Singapore.
You may also be interested in...
SINGAPORE - Pfizer expects to see drugs discovered and developed in Asia brought into the clinic in about three years, Pfizer's Pharma Therapeutics R&D Head Martin Mackay told local reporters April 7 during a press conference at the company's Clinical Research Unit at Raffles Hospital in Singapore
Sanofi, Merck Among Firms Collaborating With Asian Governments For Drug Development – World Vaccine Congress
A Thai-French joint venture will export Japanese encephalitis vaccines to 15 Asian countries starting in 2013.
Malaysia readies to launch venture capital fund worth $100 million in the second quarter to support biopharma industry.